Vittal Vasista, Chief Financial Officer at REGENXBIO Inc. (RGNX), sold 11,250 shares at $70.43 ($838K) on 2018-09-17, disclosed to the SEC on 2018-09-19.
Open-market sale of $838k RGNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.43 | 1,561 | $110K | 13.1% |
| 2 | $70.43 | 1,561 | $110K | 13.1% |
| 3 | $72.03 | 200 | $14K | 1.7% |
| 4 | $73.40 | 1,200 | $88K | 10.5% |
| 5 | $74.02 | 710 | $53K | 6.3% |
| 6 | $74.02 | 710 |
| $53K |
| 6.3% |
| 7 | $75.59 | 700 | $53K | 6.3% |
| 8 | $76.79 | 1,479 | $114K | 13.6% |
| 9 | $76.79 | 1,479 | $114K | 13.6% |
| 10 | $77.87 | 600 | $47K | 5.6% |
| 11 | $78.64 | 450 | $35K | 4.2% |
| 12 | $79.63 | 500 | $40K | 4.8% |
| 13 | $80.80 | 100 | $8K | 1.0% |
| Total | $74.45 avg | 11,250 | $838K | 100% |
| Filing → |
| RGNX | SELL | 2022-08-03 | $75K | — | Filing → |
| RGNX | SELL | 2022-07-15 | $274K | — | Filing → |
| RGNX | SELL | 2021-01-20 | $13K | — | Filing → |